[Interferon-beta treatment in patients with childhood-onset and juvenile multiple sclerosis].
Prospectively observed natural history in 10 cases of pediatric multiple sclerosis (MS), with respect to prognosis comparing to that of adult-onset MS (n=100) is presented. Poor-prognosis with severe disability was found in juvenile MS (age at onset 10-16 years old) with high annual rate of relapses in 2 years after the disease onset. The results of the long-term (2.0 to 3.5 years) beta-interferon treatment in patients with juvenile MS and the factors affecting these results are analyzed. Based on these data, together with those of published controlled clinical trials in adult-onset MS, indications for beta-interferon therapy and peculiarities of the treatment are discussed.